Riskpilot← Back to searchSign inGet full accessLighthouse Precision Oncology AB
ABActiveOrg 5594494899Möjavägen 18Economic activity was not specified by tax authority · NACE 0000Est. 20230 employees
Revenue 2025
SEK 0
EBITDA margin
—
+85% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK -2K
+85% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | +85% |
| Net profit | SEK -2K | +85% |
| Total assets | SEK 10K | -17% |
| Equity | SEK 10K | -17% |
| Employees | 0 | — |
Legal name
Lighthouse Precision Oncology AB
Org number
5594494899
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
22 september 2023
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Lindberg, Johan Fredrik Mayrhofer, Karl Markus Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget ska utveckla och tillhandahålla lösningar för precisionsonkologi, i synnerhet molekylär profilering av tumörsjukdomar.
Address
Möjavägen 18
Email
rasmussen.markus@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | — | — |
| EBITDA | −13 | −2 |
| Depreciation & amort. | −0 | −0 |
| EBIT | −13 | −2 |
| Net financials | — | — |
| Profit before tax | −13 | −2 |
| Tax | −0 | −0 |
| Net profit | −13 | −2 |
| Item | 2024 | 2025 |
|---|---|---|
| Total assets | 12 | 10 |
| Equity | 12 | 10 |
| Long-term debt | 0 | 0 |
| Short-term debt | 0 | 0 |
| Total debt | — | — |
EBITDA margin
-200000.0%
This company
15.8%
Market median
-1265923% vs market
20242025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20242025
Return on equity
-20.0%
This company
18.4%
Market median
-209% vs market
20242025
Net profit margin
-200000.0%
This company
8.1%
Market median
-2469236% vs market
20242025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20242025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20242025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BD Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Chairman | 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lighthouse Precision Oncology AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bram De Laere | Chief Executive Officer | 0 companies |
| Anna Rebecka Bergström | Board of Directors | 0 companies |
| Venkatesh Chellappa Patel | Board of Directors | 0 companies |
| Johan Fredrik Lindberg | Board of Directors | 0 companies |
| Karl Markus Mayrhofer | Chairman | 0 companies |